Top

We measure health.

Over 30 years ago, we set the standard in patient-reported outcomes (PROs). Every year, we continue to advance our science and technologies for capturing, benchmarking and interpreting actionable data from the patient’s perspective.
41M+
SURVEYS ADMINISTERED
50+
LABEL CLAIMS APPROVED
41K+
PEER-REVIEWED PUBLICATIONS

The copyright owners of SF-36v2® and SF-12v2®.

We measure health.

Over 30 years ago, we set the standard in patient-reported outcomes (PROs). Every year, we continue to advance our science and technologies for capturing, benchmarking and interpreting actionable data from the patient’s perspective.
41
SURVEYS ADMINISTERED
50
LABEL CLAIMS APPROVED
41
PEER-REVIEWED PUBLICATIONS

The copyright owners of SF-36v2® and SF-12v2®.

Your partner in patient-centric research.

Our research consultants have decades of experience in PRO measurement across diverse therapeutic conditions. We work closely with pharmaceutical, medical device and healthcare organizations on data measurement that aligns with regulatory recommendations in the U.S. and other geographies. Our scientifically led approach includes the analysis of any PRO measure, the burden of illness, and treatment effectiveness.

Scientific Consulting

Gain actionable intelligence in real time.

QualityMetric’s eCOA platform is a robust data collection, scoring and reporting portal. It can be custom tailored with the features and functionality needed to securely and accurately capture data from patients, clinicians or caregivers. Our scientists combine health outcomes expertise with our technology platform to identify the right measurement concepts for collecting the most insightful and patient-centric evidence.

COA Solutions & Licensing Services

Linguistic equivalence on every continent.

QualityMetric offers unique solutions for translation and cross-cultural adaptation. Guided by industry standards, we translate and validate all types of materials used in health care and the life sciences. We collaborate with hundreds of experienced local and international linguistic partners, overseeing every stage of the development process. Our goal is absolute conceptual equivalence, cultural appropriateness and content validity.

Translation & Linguistic Validation

The gold standard in PRO general health assessments.

QualityMetric’s Short Form family of generic health surveys – in particular the SF-36v2® and SF-12v2® – includes the most widely used and cited PROs in the world. Designed for use across the product lifecycle, they are an efficient, scientifically valid way of evaluating safety and efficacy, real world evidence through product performance, and post authorization safety surveillance; and they support post-launch direct-to-consumer (DTC) marketing and disease management.

Driving better outcomes across the life science ecosystem
Patients
Make better decisions about interventions.
Life Sciences
Gain evidence to support the development, approval and marketing of new drugs and devices.
Employers
Develop strategies for improving employee health and productivity.
Payers
Monitor patient populations, identify risks and quantify treatment benefits.
Providers
Track patient and population progress over time and measure treatment efficacy.
Driving better outcomes across the life science ecosystem
Patients
Make better decisions about interventions.
Life Sciences
Gain evidence to support the development, approval and marketing of new drugs and devices.
Employers
Develop strategies for improving employee health and productivity.
Payers
Monitor patient populations, identify risks and quantify treatment benefits.
Providers
Track patient and population progress over time and measure treatment efficacy.

Want to partner with us? Need a survey license?

QualityMetric collaborates with the world’s largest life science and healthcare organizations to measure and better understand health outcomes. We are also committed to supporting global academic institutions by making our clinical outcome assessment (COA) solutions royalty-free for students and university researchers.

From health surveys to expert analysis and methodologies, QualityMetric delivers all-inclusive outcome measurement solutions for capturing, benchmarking, and interpreting actionable patient-reported health information. For licensing requests, scientific consulting services, or linguistic translation and validation, please complete the following contact form.

Select the organization that best describes your company:

* A valid email address must be entered.
* Please ensure all fields are completed correctly. Fields colored red are invalid or incomplete.

Survey License Application

Please answer the following questions and we will be in touch regarding your license.

* Please ensure all fields are completed correctly. Fields colored red are invalid or incomplete.
of

Contact Information

* A valid email address must be entered.
* Please enter a numeric value.

Have you started or completed collecting data for your study/project?

*If yes, please email a copy of the survey being administrated to license@qualitymetric.com. We will QA the form for any changes that may affect the scoring and interpretation of the data collected. (Fees may apply).
* Please enter a numeric value.
* Please enter a numeric value.
* Please enter a numeric value.
* Please enter a numeric value.
* Please enter a numeric value.


What recall period is needed?

Who will be scoring and analyzing the data?

Which license are you applying for?

Who will be Licensee on the license agreement?

Student Information

University Information

Thank you for your request.

QualityMetric is reviewing your application and will get back to you shortly with approval to move forward with a license to administer, collect, score, and interpret the data for your project/study.

Next steps:

If you have started administering the survey, please email a copy of the survey being administered to license@qualitymetric.com. We will QA the form for any changes that may affect the scoring and interpretation of the data collected. (Fees may apply).

If you are applying for a student license, please email a copy of your student ID to license@qualitymetric.com.

Latest news updates.

01.03.21

QualityMetric Collaborates with Drug Developers to Address Pain Points of Rare Diseases

We offer several patient-reported outcome (PRO) measurement solutions that can help document the etiology, progression, patient experience, symptoms and impact of rare diseases.

01.29.21

Vesey Street Capital Partners-Backed QualityMetric Adds John Hart as Chief Financial Officer

Mr. Hart will join the team led by Chief Executive Officer Garth “Gus” Gardner, who has been in that role since soon after the VSCP-led recapitalization of the company in August of 2020.

Read More
01.07.21

QualityMetric Co-authors New Qualitative Study on hATTR

QualityMetric’s own Kimberly Raymond, Andrew Lovley, and Michelle White co-author a new study on the humanistic burden of hereditary transthyretin (hATTR) amyloidosis from the patient’s perspective.

Read More
12.30.20

QualityMetric Co-authors Study Supporting Content Validity of the ACT

QualityMetric’s Vice President and Senior Scientist, Mark Kosinski, co-authors a study for determining whether the content of the Asthma Control Test (ACT) serves as a valid measure of asthma control.

Read More
12.15.20

How We Identify the Best PRO Tools for Medical Device Manufacturers

Our experts provide medical device clients with leading strategic measurement services, qualitative and quantitative research and patient journey studies, PRO outcomes analyses, rare disease research, and PRO regulatory support services.

Read More
11.15.20

QualityMetric Develops PROs for Determining Worldwide Impact of COVID-19

As pharma, biotech, medical device companies and academic researchers race to discover treatments for COVID-19, they require measurement and outcomes reporting for capturing real-world evidence.

Read More
09.15.20

A Letter to Our Customers

We want to inform you of a recent development that will allow us to enhance the services and support we provide.

Read More